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Abstract
Objective: The mechanisms underlying the association of insulin-like growth factor-I
(IGF-I) and leg length (a marker of prepubertal growth) with cancer risk are
uncertain. One hypothesis is that diet in early childhood might provide the link. The
aim of the present study was to examine the association between early diet – in
particular, the intakes of cows’ milk and dairy products – and height, leg length and
IGF-I levels at age 7–8 years.
Subjects: Children participating in the Avon Longitudinal Study of Parents and
Children.
Design: Diet was assessed using a 3-day unweighed food record. Anthropometry,
IGF-I and insulin-like growth factor-binding protein-3 (IGFBP-3) were measured by
standard methods.
Results: Data on both diet and height were available for 744 children (404 boys) and
on diet and IGF for 538 (295 boys). After adjusting for energy, both cows’ milk and
dairy product intakes were positively associated with IGF-I (P ¼ 0.040 and 0.027,
respectively) and IGFBP-3 levels (P ¼ 0.082 and 0.067, respectively). These
associations persisted on adjustment for potential confounders, but were abolished
on controlling for protein intake. In energy-adjusted models there was only weak
evidence of associations of milk and dairy product intakes with anthropometry. In
boys only, dairy product intake was positively associated with leg length (equivalent
to a 0.058 (0.002, 0.114) standard deviation score increase in leg length per 100 g
increase in daily intake).
Conclusions: These data provide some evidence that variation in childhood milk and
dairy product intakes underlies associations of leg length, IGF-I and cancer risk. The
association appears to be due to the protein content of milk.
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Greater adult stature is associated with cancer risk, in
particular with prostate, breast and gastrointestinal
cancers1. Some evidence suggests that leg length, a
marker for growth before puberty2, is the component of
height most strongly associated with risk1,3. Growth in leg
length is thought to be more sensitive to environmental
insults than truncal growth, and adult leg length has been
suggested to be a marker of prepubertal influences on
growth such as childhood diet4. This suggests that the
biological mechanisms linking height with cancer risk may
originate in factors that influence long bone growth in
childhood. It is possible that these associations between
prepubertal growth and cancer risk operate via dietary
effects on levels of insulin-like growth factors (IGFs), as
IGFs are key hormonal regulators of growth5,6.
The IGFs are powerful mitogenic agents which
stimulate cell differentiation and inhibit apoptosis. Higher
circulating levels of insulin-like growth factor-I (IGF-I) are
associated with increased risk of a number of cancers,
including prostate7,8, breast9 and colon cancer10, the same
cancers most consistently associated with height. Some
studies have found inverse associations between concen-
trations of insulin-like growth factor-binding protein-3
(IGFBP-3) and cancer risk11,12, but a recent meta-analysis
has suggested a positive association13. The risk of these
cancers has also been associated with dietary factors,
including positive associations with intakes of energy, red
meat, animal fat, calcium and dairy products14–18, and
negative associations with fruit and vegetables18–22.
Several cross-sectional studies in adults have investigated
the relationship between diet and IGF-I levels. The results
are mixed, but one of the more consistent relationships is a
positive association between cows’ milk or dairy product
intake and IGF-I10,23–25, although this is not observed in all
studies26 – 28. Milk supplementation has also been
observed to raise IGF-I levels in three studies, one of
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middle-aged men and women29, one of adolescent girls30
and one in 8-year-old boys31. However, it remains unclear
what constituent of cows’ milk/dairy products is respon-
sible for their positive effect on circulating IGF-I.
Evidence that childhood diet may affect adult cancer
risk is provided by a long-term follow-up of the Boyd Orr
cohort, which found that childhood energy intakes were
positively associated with cancer mortality in adulthood32.
The associations of dietary intakes in prepubertal children
with IGF levels and growth have been less often studied
but are of considerable interest. Such associations could
confirm that leg length measures are a marker of
childhood nutrition and that IGF-I is the biological
mediator of the associations of diet and anthropometry
with cancer risk in later life. The associations of cows’ milk
and dairy products with IGF-I are of particular interest in
this context, as children are high consumers of these
foods, often marketed as ‘healthy’ foods for this age group.
However, we are aware of only one study that has
investigated the associations of milk and dairy product
intakes with both IGF-I and measures of linear growth in
children33.
The aim of the present study was to investigate
associations of cows’ milk and dairy product intakes
with levels of IGF-I and IGFBP-3 in a group of 7- and 8-
year-old children in the South West of England. In addition
we examined the associations between these foods and
height and leg length – possible biomarkers of IGF-I4,6.
Methods
This study was based on the Avon Longitudinal Study of
Parents and Children (ALSPAC), a geographically based
cohort study investigating factors influencing the health,
growth and development of children34. All pregnant
women resident within a defined part of the former county
of Avon in South West England with an expected date of
delivery between April 1991 and December 1992 were
eligible. Between 80% and 90% of these enrolled (14 541
pregnancies resulting in 14 062 live births)35. Ethical
approval for the study was obtained from the relevant
local ethics committees. Data in ALSPAC are collected by
self-completion postal questionnaires, abstracted from
medical records, and from examination of the children at
research clinics.
The children forming the basis of the present analysis
were part of a randomly selected 10% sub-cohort of
ALSPAC called Children in Focus (CIF) (n ¼ 1432)35. The
children attended research clinics at 7–8 years of age
where diet was assessed, growth measurements were
made and a blood sample was taken.
Assessment of diet
Diet was assessed using a 3-day unweighed dietary record
completed by the child’s carer in advance of the clinic, and
checked for completeness by a trained assistant during the
clinic visits. These were coded using the coding package
DIDO36, and analysed using a database consisting of the
5th edition of McCance & Widdowson’s The Composition
of Foods37 and its supplements38–46. Nutrient intakes from
dietary supplements were not assessed; 9.3% of children
were reported to take a vitamin or mineral supplement of
some kind, and 0.7% of children took cod-liver oil.
Measurement of anthropometric variables
Height, leg length and sitting height were measured to the
last completed millimetre using a Harpenden stadiometer,
a sitting height table and an anthropometer as described
by Cameron47. Weight was measured to the nearest 50 g
using a Tanita weighing scale (Tanita UK Limited,
Uxbridge). Body mass index (BMI) was calculated as
weight (kg)/[height (m)]2.
Measurement of other variables
Information on maternal education, housing tenure,
paternal social class and maternal smoking in pregnancy
was obtained from a self-completion questionnaire sent to
the mother at 32 weeks’ gestation. Birth weight, sex of the
child and gestation were obtained from hospital records.
Gestational age was assessed on the basis of date of last
menstrual period, ultrasound assessment and other clinical
indicators.
Assessment of IGF levels
Serum levels of IGF-I were determined in venous blood by
radioimmunoassay using a monoclonal antibody (Blood
Products, Elstree, Hertfordshire, UK) and recombinant
peptide (Pharmacia, Stockholm, Sweden) for standard and
tracer, following iodination using the chloramine-T
method. Samples were analysed following acid–acetone
extraction to remove the IGFBPs with an excess of IGF-II
added to the extract in order to saturate any residual
binding proteins48. Serum levels of IGFBP-3 were
determined by radioimmunoassay using an in-house
polyclonal antibody raised against recombinant non-
glycosylated IGFBP-3. The assay was calibrated against
recombinant glycosylated IGFBP-3 (Dr C Maack, Celitrix,
Santa Clara, CA, USA). The molar ratio of IGF-I/IGFBP-3
was calculated by multiplying the concentration ratio by
5.33 (based on the molecular weights of IGF-I (7500) and
IGFBP-3 (40 000)). The average coefficients of variation for
intra-assay variability for IGF-I and IGFBP-3 were 6.7%
and 3.6%, and for inter-assay variation were 12% and 14%.
Statistical methods
All hormone levels and anthropometric variables were
adjusted for age. IGF-I, IGFBP-3 and IGF-I/IGFBP-3 were
transformed to the natural logarithm prior to age
adjustment in order to reduce skewness. Age-adjusted
anthropometric variables were converted to sex-specific
Z-scores (Z-scores were produced with reference to the
ALSPAC cohort).
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Intakes of cows’ milk and dairy products were the main
predictor variables of interest. Cows’ milk was defined as
the sum of whole, semi-skimmed and skimmed milk.
Dairy products were defined as the sum of cows’ milk,
other milk (i.e. dried milk, evaporated milk and cream),
cheese, yoghurt, milk-based sauces, ice cream and milk
chocolate. Intakes of calcium, protein and animal protein
were also considered as possible mediators of the effects
of cows’ milk and dairy products. Intakes of calcium,
protein and animal protein were adjusted for energy using
the residuals method49.
The following confounding variables were considered:
maternal education, housing tenure, birth weight and the
child’s BMI. Highest maternal educational level was
grouped as CSE (Certificate of Secondary Education) or
equivalent or no qualifications, vocational qualifications,
O-level or equivalent, A-level or equivalent, or university
degree (CSE and O-levels are respectively lower and
higher levels of qualifications taken at around 16 years of
age, A-levels are the standard qualifications taken at
around 18 years of age). Housing tenure was grouped as
council rented (i.e. government housing), other rented,
and owned/mortgaged. Birth weight was adjusted for
gestational age and converted to sex-specific Z-scores.
Paternal social class and maternal smoking in pregnancy
were also initially considered as potential confounders,
but found to be minimally associated with IGF or growth
once the other confounders had been considered.
Only white children not from multiple births were
included in analyses, as preliminary analyses suggested
that the growth and IGF levels of children from non-white
ethnic groups differed from those of white children, and
there were too few children from non-white ethnic groups
to analyse separately. After excluding subjects who were
non-white or from multiple births, there were 744 subjects
with both diet and height measures (i.e. 59% of the white
singleton children in the CIF sub-cohort) and 538 with
both diet and IGF. Multivariate models are based on a
smaller subset of subjects (n ¼ 521 children, 287 boys)
with complete information on all confounders.
Linear (least squares) regression models were used.
Initial statistical analyses were performed firstly for both
sexes together and then separately for boys and girls, as
previous studies have shown that IGF-I and IGFBP-3 levels
differ between boys and girls6,50, and the relationship
between IGF-I and IGFBP-3 and age is also different
between boys and girls50. In the first instance the
association between cows’ milk and dairy products and
the outcome variables was assessed controlling for energy
only. Subsequent multivariable regression analyses
included other confounders and were based on a
subgroup of children where complete data were available;
the confounding variables included in the statistical
models were as follows: (1) energy intake (Model 1); (2)
energy intake, housing tenure, maternal education, birth
weight and BMI (Model 2); (3) factors included in Model 2
plus IGF-I for models looking at height, leg length and
sitting height, or height in models looking at IGF-I, IGFBP-
3 and IGF-I/IGFBP-3 (Model 3); (4) in Models 4–6 we
examined the effect of adjusting additionally for those
nutrient variables that we felt might mediate any
associations with cows’ milk and dairy products, i.e.
calcium, protein and animal protein.
In order to assess the possible effects of underreporting
of dietary intake, all analyses were repeated excluding
those children reporting an energy intake of less than
1.39 £ estimated basal metabolic rate (BMR) for boys or
1.30 £ BMR for girls51.
All analyses were performed using SPSS version 10
(SPSS Inc., Chicago, IL, USA).
Results
Response rate and representativeness of sample
Some characteristics of study members are displayed in
Table 1. IGF-I and IGFBP-3 were higher in girls than boys,
but IGF-I/IGFBP-3 was similar in the two sexes. The
children were slightly taller and heavier than national
growth standards52.
Girls (but not boys) for whom data on IGF levels were
available were significantly taller with longer legs than
those for whom data on IGF levels were not available
(mean height and leg length in those with and without IGF
measures were 125.5 cm and 124.1 cm, P ¼ 0.019 and
57.8 cm and 57.0 cm, P ¼ 0.031 respectively). Children
with data on IGF were less likely to live in council housing
Table 1 Mean (SD) IGF-I and IGFBP-3 levels, growth measures
and dietary intakes in boys and girls
Boys Girls
n ¼ 404* n ¼ 340*
Mean age (years) 7.48 (0.12) 7.49 (0.11)
Height (cm)† 125.9 (5.0) 125.2 (5.4)
Weight (kg)‡ 25.7 (4.4) 25.7 (4.8)
Sitting height (cm) 68.1 (2.7) 67.6 (2.7)
Leg length (cm) 57.8 (3.0) 57.6 (3.4)
BMI (kg m22) 16.1 (1.9) 16.3 (2.3)
Cows’ milk intake (g) 278 (195) 243 (187)
Dairy products intake (g) 348 (209) 313 (193)
Energy intake (kJ) 7295 (1339) 6858 (1211)
Calcium intake (mg) 810 (280) 757 (256)
Protein intake (g) 56.7 (12.8) 52.8 (11.5)
Animal protein intake (g) 33.8 (11.4) 31.4 (10.4)
n ¼ 295§ n ¼ 243§
IGF-I (ng ml21) 145 (55) 154 (52)
IGFBP-3 (ng ml21) 4883 (1669) 5122 (1943)
IGF-I/IGFBP-3 0.167 (0.063) 0.172 (0.058)
SD – standard deviation; IGF-I – insulin-like growth factor-I; IGFBP-3 –
insulin-like growth factor-binding protein-3; BMI – body mass index.
* The sample used is those boys and girls with both a diet and a height
measure.
† Median height from UK reference data: 124.9 cm (boys)/124.3 cm
(girls)52.
‡ Median weight from UK reference data: 24.3 kg (boys)/24.4 kg (girls)52.
§ The sample used is those boys and girls with both IGF and a diet
measure.
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(8.4% vs. 14.3%, P , 0.001) and less likely to have a
mother whose highest educational qualification was CSE
or less (10.4% vs. 18.7%, P , 0.001).
Univariable analyses
Table 2 shows geometric mean levels of IGF-I, IGFBP-3
and IGF-I/IGFBP-3 by quartile of cows’ milk and dairy
products intakes. Among both sexes after adjusting for
energy intake, cows’ milk and dairy products were
positively associated with IGF-I (P ¼ 0.040 and 0.027,
respectively) and weakly positively associated with
IGFBP-3 (P ¼ 0.082 and 0.067, respectively). Among
boys, after adjustment for energy intake, cows’ milk was
weakly positively associated with IGF-I (P ¼ 0.084) and
significantly positively associated with IGFBP-3
(P ¼ 0.024). Dairy products were also positively associ-
ated with IGF-I and IGFBP-3, with a difference in IGF-I
concentrations of approximately 20 ng ml21 between the
lowest and highest quartiles of dairy products intake.
Among girls, neither cows’ milk nor dairy products intake
was associated with either IGF-I or IGFBP-3. These
gender-specific subgroup findings should be interpreted
with caution, as there was little statistical evidence that
effects of diet on IGF differed in boys and girls. The P-
values for the interaction terms gender £ cows’ milk and
gender £ dairy products on IGF-I were 0.37 and 0.16,
respectively, and for IGFBP-3 were 0.13 and 0.16,
respectively. IGF-I/IGFBP-3 was not associated with
cows’ milk or dairy products in either the whole sample
or boys and girls separately (data not shown).
Table 3 shows mean Z-scores for height, leg length and
sitting height according to intakes of cows’ milk and dairy
products. On adjusting for energy intake there were no
clear associations between intake of either food group and
anthropometry, except for a weak positive association
between dairy products and leg length in boys
(P ¼ 0.069). There was some evidence that diet–anthro-
pometry associations differed in boys and girls. The P-
values for the interaction terms cows’ milk £ gender and
dairy products £ gender with respect to height were 0.040
and 0.043, respectively, and for leg length were 0.013 and
0.015, respectively.
Multivariable analyses
Table 4 shows the associations of cows’ milk and dairy
products with IGF-I and IGFBP-3 in multivariable analyses
in all children. The univariable positive associations
between cows’ milk and dairy products and IGF-I remained
significant in the subset with complete data. Of the possible
confounding/mediating factors investigated, only protein/
Table 2 Geometric mean (95% CI) IGF-I and IGFBP-3 levels according to quartile of cows’ milk or dairy products intake (quartiles calcu-
lated separately in boys and girls)
Quartile of intake
1 (low) 2 3 4 (high) P * P †
Both sexes
Cows’ milk (n ¼ 143) (n ¼ 135) (n ¼ 136) (n ¼ 124)
Median intake (g) 67 187 301 462
IGF-I (ng ml21) 133.6 (125.4, 142.4) 139.0 (130.5, 148.2) 141.0 (133.1, 149.3) 141.8 (134.1, 150.0) 0.017 0.040
IGFBP-3 (ng ml21) 4467 (4262, 4681) 4661 (4434, 4899) 4709 (4477, 4953) 4749 (4503, 5009) 0.011 0.082
Dairy products (n ¼ 131) (n ¼ 141) (n ¼ 133) (n ¼ 133)
Median intake (g) 113 257 401 631
IGF-I (ng ml21) 133.8 (125.3, 143.0) 138.8 (130.3, 147.9) 138.0 (130.3, 146.1) 144.3 (136.6, 152.4) 0.010 0.027
IGFBP-3 (ng ml21) 4451 (4230, 4683) 4599 (4389, 4819) 4688 (4457, 4931) 4831 (4588, 5088) 0.005 0.067
Boys
Cows’ milk (n ¼ 76) (n ¼ 72) (n ¼ 75) (n ¼ 72)
Median intake (g) 67 200 314 503
IGF-I (ng ml21) 123.7 (112.4, 136.1) 137.2 (126.5, 148.8) 136.8 (125.8, 148.7) 139.5 (128.8, 151.1) 0.023 0.084
IGFBP-3 (ng ml21) 4359 (4080, 4656) 4474 (4216, 4748) 4635 (4322, 4970) 4809 (4486, 5155) 0.003 0.024
Dairy products (n ¼ 70) (n ¼ 76) (n ¼ 74) (n ¼ 75)
Median intake (g) 123 260 397 588
IGF-I (ng ml21) 125.3 (113.7, 138.1) 132.5 (121.7, 144.3) 132.9 (122.6, 144.0) 145.5 (134.5, 157.5) 0.006 0.031
IGFBP-3 (ng ml21) 4383 (4073, 4716) 4410 (4180, 4652) 4540 (4229, 4873) 4933 (4617, 5272) 0.002 0.022
Girls
Cows’ milk (n ¼ 67) (n ¼ 63) (n ¼ 61) (n ¼ 52)
Median intake (g) 65 167 293 442
IGF-I (ng ml21) 145.9 (135.0, 157.8) 141.2 (127.4, 156.4) 146.3 (135.3, 158.2) 145.1 (134.1, 157.0) 0.34 0.29
IGFBP-3 (ng ml21) 4592 (4293, 4911) 4883 (4496, 5304) 4801 (4456, 5174) 4668 (4288, 5081) 0.61 0.90
Dairy products (n ¼ 61) (n ¼ 65) (n ¼ 59) (n ¼ 58)
Median intake (g) 109 228 358 499
IGF-I (ng ml21) 144.3 (132.3, 157.3) 146.6 (133.2, 161.4) 144.6 (133.4, 156.8) 142.7 (132.3, 154.0) 0.53 0.44
IGFBP-3 (ng ml21) 4530 (4218, 4865) 4830 (4460, 5241) 4880 (4540, 5245) 4703 (4326, 5112) 0.49 0.84
CI–confidence interval; IGF-I – insulin-like growth factor-I; IGFBP-3 – insulin-like growth factor-binding protein-3.
*P-value for continuous variable.
†P-value for continuous variable adjusted for energy intake.
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animal protein intake strongly attenuated the association of
IGF-I with cows’ milk and dairy products. There was no
strong evidence of confounding of the IGFBP-3 association
with cows’ milk and dairy products. Controlling for calcium
increased the size of the regression coefficient of cows’
milk/dairy products on IGFBP-3. No significant associ-
ations wereobserved between cows’ milk or dairy products
intake and IGF-I/IGFBP-3 (data not shown).
As mentioned above, the only confounding factor to
markedly attenuate the association of cows’ milk/dairy
products with IGF-I was protein. Cows’ milk and dairy
products were a major source of protein, with
dairy products accounting on average for 40% of the
children’s animal protein intake, in comparison with 17%
and 14% from poultry and processed meat, the next two
highest sources. The regression coefficients (b (standard
error)) for the energy-adjusted associations of total, dairy
and non-dairy protein with IGF-I were respectively
0.00747 (0.00171), P , 0.001; 0.00493 (0.00217),
P ¼ 0.023; and 0.00506 (0.00185), P ¼ 0.006. The
regression coefficients for dairy and non-dairy protein
were very similar, implying that protein per se rather than
Table 5 Change in height and leg length Z-score for each 100 g increase in cows’ milk/dairy product consumption among boys (n ¼ 287)
Cows’ milk Dairy products
Outcome variable B (95% CI) P B (95% CI) P
Height
Model 1 0.023 (20.038, 0.084) 0.46 0.038 (20.020, 0.096) 0.20
Model 2 0.029 (20.024, 0.083) 0.28 0.035 (20.016, 0.085) 0.18
Model 3 0.004 (20.047, 0.055) 0.87 0.011 (20.037, 0.059) 0.65
Model 4 20.022 (20.113, 0.070) 0.64 0.000 (20.102, 0.103) 1.00
Model 5 0.015 (20.042, 0.072) 0.60 0.023 (20.031, 0.076) 0.41
Model 6 0.012 (20.047, 0.071) 0.68 0.022 (20.035, 0.078) 0.45
Leg length
Model 1 0.047 (20.012, 0.106) 0.12 0.058 (0.002, 0.114) 0.041
Model 2 0.050 (20.004, 0.105) 0.069 0.054 (0.003, 0.105) 0.038
Model 3 0.027 (20.025, 0.079) 0.31 0.032 (20.017, 0.081) 0.20
Model 4 20.022 (20.116, 0.071) 0.64 20.008 (20.113, 0.096) 0.88
Model 5 0.043 (20.015, 0.101) 0.15 0.048 (20.006, 0.103) 0.083
Model 6 0.041 (20.019, 0.101) 0.18 0.049 (20.008, 0.106) 0.094
CI – confidence interval.
Model 1 – adjusted for energy intake; Model 2 – adjusted for energy intake, housing tenure, maternal education, birth weight and body mass index (BMI);
Model 3 – adjusted for energy intake, housing tenure, maternal education, birth weight, BMI and insulin-like growth factor-I (IGF-I); Model 4 – adjusted for
energy intake, housing tenure, maternal education, birth weight, BMI, IGF-I and calcium intake; Model 5 – adjusted for energy intake, housing tenure,
maternal education, birth weight, BMI, IGF-I and protein intake; Model 6 – adjusted for energy intake, housing tenure, maternal education, birth weight, BMI,
IGF-I and animal protein intake.
Table 4 Percentage change in IGF-I and IGFBP-3 per 100 g increase in cows’ milk or dairy products con-
sumption among both sexes (n ¼ 521)
Cows’ milk Dairy products
Outcome variable B (95% CI) P B (95% CI) P
IGF-I
Model 1 2.12 (0.40, 3.87) 0.014 2.12 (0.50, 3.87) 0.011
Model 2 2.33 (0.60, 3.98) 0.007 2.12 (0.50, 3.77) 0.011
Model 3 2.33 (0.70, 3.98) 0.004 2.02 (0.50, 3.67) 0.009
Model 4 2.02 (20.80, 4.92) 0.17 1.41 (21.88, 4.71) 0.42
Model 5 0.90 (20.80, 2.74) 0.29 0.60 (21.09, 2.33) 0.47
Model 6 1.11 (20.70, 2.94) 0.24 0.70 (21.09, 2.53) 0.46
IGFBP-3
Model 1 1.41 (0.00, 3.23) 0.046 1.41 (0.00, 2.74) 0.046
Model 2 1.51 (0.10, 2.94) 0.036 1.31 (20.10, 2.63) 0.061
Model 3 1.51 (0.10, 2.94) 0.032 1.31 (20.10, 2.63) 0.061
Model 4 2.63 (0.10, 5.13) 0.039 2.53 (20.30, 5.55) 0.077
Model 5 1.41 (20.09, 2.94) 0.074 1.11 (20.40, 2.63) 0.14
Model 6 1.82 (0.20, 3.36) 0.029 1.51 (20.10, 3.15) 0.058
CI – confidence interval; IGF-I – insulin-like growth factor-I; IGFBP-3 – insulin-like growth factor-binding protein-3.
Model 1 – adjusted for sex and energy intake; Model 2 – adjusted for sex, energy intake, housing tenure, maternal
education, birth weight and body mass index (BMI); Model 3 – adjusted for sex, energy intake, housing tenure, maternal
education, birth weight, BMI and height; Model 4 – adjusted for sex, energy intake, housing tenure, maternal education,
birth weight, BMI, height and calcium intake; Model 5 – adjusted for sex, energy, housing tenure, maternal education, birth
weight, BMI, height and protein intake; Model 6 – adjusted for sex, energy, housing tenure, maternal education, birth weight,
BMI, height and animal protein intake.
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dairy protein was the important factor. Thus these results
are consistent with the cows’ milk–IGF-I associations
being mediated by protein.
Table 5 shows the multivariable associations of cows’
milk and dairy products with anthropometry in boys. This
analysis was restricted to boys as there was no evidence of
any association of anthropometry with cows’ milk/dairy
products in females (see above). Leg length was the
anthropometric variable with the strongest relationship
with dairy products. Of the confounding factors investi-
gated, only adjustment for IGF-I and calcium strongly
attenuated the association between dairy products and leg
length, indicating that these factors may mediate the
association. A similar pattern was obtained in the models
with height as the outcome, but the regression coefficients
were smaller in each case. There was no evidence of a
positive relationship between dairy products and sitting
height (data not shown).
Effect of excluding underreporters
The analyses were repeated excluding possible under-
reporters (76 children excluded). The results were similar,
but the associations between dairy products and IGFBP-3
and between dairy products and leg length in boys were
slightly attenuated (data not shown).
Discussion
Among this group of 7- and 8-year-old children we found
a number of associations between milk and dairy products
consumption and IGF-I and its main binding protein
IGFBP-3. Higher intakes of cows’ milk and dairy products
were significantly positively associated with concen-
trations of IGF-I and IGFBP-3 in all children and in boys,
even after adjusting for a number of possible confounders.
However, there were no associations between cows’ milk
or dairy products and the molar ratio IGF-I/IGFBP-3, a
possible marker of IGF-I bioavailability. There were also
no associations between IGF levels and cows’ milk or
dairy products in girls.
The associations between cows’ milk/dairy products
and IGF-I and IGFBP-3 were considerably more attenu-
ated on adjustment for total or animal protein than for
calcium. Furthermore, protein and animal protein from
both all sources and non-dairy sources were positively
associated with IGF-I in boys, and the strength of the
associations with dairy and non-dairy protein were similar.
This suggests that the apparent relationship between milk
and IGF-I could reflect an underlying association with
protein rather than with milk per se. In this group of
children dairy products comprised the largest source of
animal protein in their diet (see Appendix).
Dairy product intake was positively associated with leg
length in boys. This association was considerably
attenuated by adjustment for IGF-I, suggesting it may be
one of the biological mediators of this association,
although studies in adults on the association between
IGF-I and height/leg length have had mixed results53,54.
We speculated that the absence of associations between
diet and anthropometry in girls might be related to the
early onset of adrenarche or puberty in some of the older
girls. Therefore the analysis was repeated in girls aged less
than 8 years at the time of IGF measurement (approxi-
mately 40% of the original sample). In this subgroup we
found, contrary to expectations, an inverse association
between cows’ milk and leg length (in Model 3,
b ¼ 20.109 (20.196, 20.022) standard deviation score
in leg length per 100 g increase in cows’ milk intake).
However, these were post hoc analyses and so should be
interpreted with caution. In addition, there was no
evidence of a statistical interaction between cows’ milk/
dairy products and age with respect to their effect on IGF-I
(among girls the P-values for the interaction terms
age £ cows’ milk and age £ dairy products were 0.19
and 0.14, respectively).
Strengths and limitations of the current study
As far as we are aware, this is the first study to relate
childhood diet to both leg length and IGF-I. Previous
studies of diet–IGF associations have generally used food-
frequency questionnaires. We assessed diet using a 3-day
unweighed food record. Unweighed food records have
been shown to compare well with the results of weighed
intakes, generally considered the gold standard of dietary
assessment55. One problem with food-frequency ques-
tionnaires is their limited ability to estimate energy intake,
which has been shown to be positively associated with
IGF-I levels56. As a result, despite attempts to control for
energy intake, residual confounding by this factor may
remain. The current study had good information on a
range of sociodemographic confounders – most previous
studies have made no attempt to control for any measure
of social status. Controlling for these confounders had very
little effect on the observed associations, suggesting it is
unlikely that socially patterned confounding accounts for
the relationships we have observed. However, a limitation
of the analysis is its cross-sectional nature, which means it
cannot determine the causality of any relationships
between IGF-I levels and diet. In addition our sample
was slightly biased in terms of socio-economic status, and
in favour of taller girls, which may have removed some of
the variation in diet and IGF levels and made it harder to
detect significant relationships.
Findings of other studies
Most previous studies of the relationship between cows’
milk and IGFs have been conducted in middle-aged and
elderly men. Two large studies in the USA10,23 and one in
the UK24 have found positive associations between milk/
dairy intake and IGF-I levels that persisted on adjustment
for potential confounders. Relationships with protein
intakes in these studies were less consistent. Two small
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studies of elderly men in Greece (n ¼ 15327 and 11228)
found no association between cows’ milk/dairy products
and IGF-I, but may have lacked the statistical power to
detect associations of the size seen in the other studies.
There have been two studies in women, one in the USA25
and one in the UK26. Only the US study found a positive
association with cows’ milk/dairy products, but both
studies found evidence of positive associations between
protein intake and IGF-I.
We are aware of only one other study that has
investigated the relationship between milk intake and
IGF-I and linear growth in children. Among 90 Danish 2-
year-olds, intakes of milk and animal protein were
positively associated with serum IGF-I and height in an
analysis adjusting for body size, while intakes of vegetable
protein and meat were not33.
Conclusions
We have found a positive association between cows’ milk
and dairy products and IGF levels in 7–8-year-old children
that appears to be at least partly mediated by levels of
protein intake. These results are in line with the majority of
adult studies. Dairy product intake in boys was also
positively associated with leg length, providing a possible
mechanistic link with IGF-I mediating the effects of
nutrition on long bone growth and the risk of cancer in
adulthood. Conversely, cows’ milk intake in the younger
girls was inversely associated with leg length. It is unclear
from these results how a recommendation to reduce
intake of dairy products would affect IGF-I levels and
prepubertal growth. Furthermore, there are a number of
possible detrimental effects of reducing IGF-I levels.
Lower IGF-I levels in adults have been linked to heart
disease57, diabetes58 and unfavourable changes in body
composition in later life. In addition, higher IGF-I levels
are associated with increased bone mineral density. Milk
supplementation studies have found favourable effects on
bone remodelling in adults29 and on bone mineral content
in children30, in addition to the effects on IGF-I. Any
dietary recommendations should await a more complete
understanding of the complex effects of IGF-I on long-
term health and more conclusive evidence on the
relationship between diet and IGF-I.
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Appendix – Correlation matrices of hormonal, anthropometric and dietary variables
Height Leg length Sitting height Cows’ milk Dairy products Calcium Protein Animal protein Energy
Boys
IGF-I 0.388*** 0.358*** 0.332*** 0.144* 0.175** 0.141* 0.235*** 0.191** 0.114*
IGFBP-3 0.268*** 0.271*** 0.201*** 0.143* 0.166** 0.111 0.143* 0.087 0.153**
Molar ratio 0.186*** 0.151** 0.184** 0.022 0.041 0.057 0.130* 0.129* 20.004
Height 0.909*** 0.872*** 0.171** 0.200*** 0.105* 0.096 0.064 0.253***
Leg length 0.589*** 0.177*** 0.205*** 0.144** 0.082 0.065 0.205***
Sitting height 0.111* 0.134** 0.038 0.089 0.048 0.247***
Cows’ milk 0.961*** 0.771*** 0.369*** 0.410*** 0.367***
Dairy products 0.799*** 0.370*** 0.435*** 0.429***
Calcium 0.482*** 0.483*** NA
Protein 0.875*** NA
Girls
IGF-I 0.189** 0.112 0.231*** 0.007 20.020 0.055 0.115 0.090 20.021
IGFBP-3 0.202*** 0.154** 0.207*** 0.048 0.056 20.032 20.029 20.049 0.101
Molar ratio 0.014 20.022 0.050 0.016 20.021 0.085 0.142* 0.135* 20.112
Height 0.912*** 0.868*** 20.042 0.005 20.020 20.049 20.085 0.159**
Leg length 0.588*** 20.069 20.028 20.045 20.041 20.077 0.135*
Sitting height 20.009 0.036 0.000 20.046 20.073 0.147**
Cows’ milk 0.945*** 0.721*** 0.412*** 0.462*** 0.170**
Dairy products 0.756*** 0.415*** 0.485*** 0.250***
Calcium 0.491*** 0.505*** NA
Protein 0.890*** NA
IGF-I – insulin-like growth factor-I; IGFBP-3 – insulin-like growth factor-binding protein-3; NA – not applicable.
*, P , 0.05; **, P , 0.01; ***, P , 0.001.
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